Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial.

Thompson, Jennifer A; Kityo, Cissy; Dunn, David; Hoppe, Anne; Ndashimye, Emmanuel; Hakim, James; Kambugu, Andrew; van Oosterhout, Joep J; Arribas, Jose; Mugyenyi, Peter; +3 more... Walker, A Sarah; Paton, Nicholas I; Europe–Africa Research Network for Evaluation of Second-line The; (2018) Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial. Clinical infectious diseases, 68 (7). pp. 1184-1192. ISSN 1058-4838 DOI: https://doi.org/10.1093/cid/ciy589

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/cid/ciy589

Abstract

Share

Download

Filename: Evolution of protease inhibitor_GREEN AAM.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar